Company / Shareholders' Equity
Connect Biopharma Holdings Ltd Shareholders' Equity History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$42.0M
FY2025
5-year range
$42.0M / $101.5M
FY2024-FY2025
Trend
-58.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$42M in FY2025.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, shareholders' equity decreased 58.6% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -7.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $42.0M | -58.6% |
| FY2024 | $101.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026